Rang	Name	Position
1	Dr. David Scott Zaccardelli Pharm.D.	President, CEO & Executive Director
2	Mr. Mark W. Hahn CPA	Chief Financial Officer
3	Mr. Andrew Fisher	General Counsel
4	Dr. Kathleen A. Rickard M.D.	Chief Medical Officer
5	Ms. Victoria Stewart	Senior Director of Investor Relations & Communications
6	Mr. Matthew Casbon	VP of Sales, Marketing & Training
7	Ms. Ostra Jewell	Senior Vice President of Human Resources
8	Dr. Tara Rheault M.P.H., Ph.D.	Chief Development Officer
9	Mr. Christopher Martin	Chief Commercial Officer
10	Ms. Caroline Diaz	Chief Regulatory Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HHG PLC	7,09%	0,64 Mrd. USD
2	Perceptive Advisors LLC	6,37%	0,58 Mrd. USD
3	Darwin Global Management, Ltd.	4,77%	0,43 Mrd. USD
4	RTW INVESTMENTS, LLC	3,53%	0,32 Mrd. USD
5	Eventide Asset Management, LLC	3,14%	0,29 Mrd. USD
6	Goldman Sachs Group Inc	3,03%	0,28 Mrd. USD
7	NEA Management Company, LLC	2,62%	0,24 Mrd. USD
8	SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	2,48%	0,23 Mrd. USD
9	Farallon Capital Management, L.L.C.	2,09%	0,19 Mrd. USD
10	T. Rowe Price Associates, Inc.	2,07%	0,19 Mrd. USD
11	Wellington Management Company LLP	1,88%	0,17 Mrd. USD
12	Hood River Capital Management LLC	1,81%	0,16 Mrd. USD
13	Caligan Partners LP	1,66%	0,15 Mrd. USD
14	D. E. Shaw & Co LP	1,64%	0,15 Mrd. USD
15	Citadel Advisors Llc	1,61%	0,15 Mrd. USD
16	Vivo Capital, LLC	1,61%	0,15 Mrd. USD
17	UBS Group AG	1,37%	0,13 Mrd. USD
18	Franklin Resources Inc	1,34%	0,12 Mrd. USD
19	Federated Hermes Inc	1,33%	0,12 Mrd. USD
20	Holocene Advisors, LP	1,24%	0,11 Mrd. USD